The ACME Laboratories Ltd. announcements
156 Dhaka Stock Exchange announcements for The ACME Laboratories Ltd. (ACMELAB) since 2016: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2017 (14).
- Credit Rating Result
Credit Rating Information and Services Limited (CRISL) has rated the Company as "AA-" in the long term and "ST-3 " in the short term along with a stable outlook in consideration of its audited financials up to June 30, 2017; un-audited financials up to September 30, 2017 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 1.99 for July-September, 2017 as against Tk. 1.79 for July-September, 2016; NOCFPS was Tk. 3.60 for July-September, 2017 as against Tk. 1.74 for July-September, 2016. NAV per share was Tk. 82.14 as on September 30, 2017 and Tk. 80.13 as of June 30, 2017.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2017.
- Resumption after Record Date
Trading of the shares of the Company will resume on 01.11.2017 after record date.
- Suspension for Record Date
Trading of the shares of the Company will remain suspended on record date i.e., 31.10.2017.
- Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefits from 29.10.2017 to 30.10.2017. Trading of the shares of the Company will remain suspended on record date i.e., 31.10.2017.
- Dividend Declaration
The Board of Directors has recommended 35% cash dividend for the year ended on June 30, 2017. Date of AGM: 04.12.2017, Time: 10:30 AM, Venue: PSC Convention Hall, Mirpur-14 Dhaka-1206. Record Date: 31.10.2017. The Company has also reported EPS of Tk. 6.61, NAV per share of Tk. 80.13 and NOCFPS of Tk. 6.60 for the year ended on June 30, 2017 as against Tk. 6.55, Tk. 77.34 and Tk. 6.25 respectively for the same period of the previous year.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (10.10.2017) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 09, 2017 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2017.
- Up gradation of ISO certification
The Company has informed that they have received the certificate of up gradation of ISO Standard from 9001:2008 to 9001:2015 version after a thorough audit of all relevant departments of Plant, Head office and Depots by Orion Registrar, Inc., USA. As per certificate of certification used by the Orion Registrar Inc., USA, The Quality management System is applicable to Marketing, Human Resources and Supply Chain etc. of Human and Veterinary Pharmaceuticals Products of the Company. (cont.) (continuation news of ACMELAB): The ACME Laboratories Limited is the first certified Company of Orion Registrar Inc., USA that has successfully upgraded its existing ISO certification under 9001:2015 among the Pharmaceuticals Companies in Bangladesh. (end)
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 1.82 for January-March, 2017 as against Tk. 1.55 for January-March, 2016; EPS was Tk. 5.42 for July, 2016-March, 2017 as against Tk. 4.48 for July, 2015-March, 2016. NOCFPS was Tk. 5.18 for July, 2016-March, 2017 as against Tk. 6.31 for July, 2015-March, 2016. NAV per share was Tk. 79.27 as of March 31, 2017 and Tk. 77.34 as of June 30, 2016.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2017 at 10:00 AM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2017.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 1.81 for October-December, 2016 as against Tk. 1.50 for October-December, 2015; EPS was Tk. 3.60 for July-December, 2016 as against Tk. 2.93 for July-December, 2015. NOCFPS was Tk. 4.01 for July-December, 2016 as against Tk. 3.16 for July-December, 2015. NAV per share was Tk. 77.43 as of December 31, 2016 and Tk. 77.34 as of June 30, 2016.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2017 at 12:00 Noon to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2016.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.